News
Archer-Daniels-Midland's Q1 earnings report showed weak performance, reflecting ongoing earnings and profit pressure. See why ...
Key Insights The projected fair value for Duopharma Biotech Berhad is RM1.62 based on 2 Stage Free Cash Flow to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback